- Home
- GEVO vs CBLL Comparison
GEVO vs CBLL Comparison
Compare GEVO & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GEVO | CBLL |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | |
| Sector | Industrials | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 470.1M | 865.4M |
| IPO Year | 2011 | 2024 |
Fundamental Metrics
Financial Performance| Metric | GEVO | CBLL |
|---|---|---|
| Price | $2.07 | $22.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $6.42 | ★ $24.67 |
| AVG Volume (30 Days) | ★ 2.7M | 461.2K |
| Earning Date | 03-05-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $120,932,000.00 | $82,813,000.00 |
| Revenue This Year | $913.54 | $37.43 |
| Revenue Next Year | $11.79 | $27.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 675.75 | 37.93 |
| 52 Week Low | $0.92 | $10.01 |
| 52 Week High | $2.95 | $26.04 |
Technical Indicators
Market Signals| Indicator | GEVO | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 47.46 | 66.90 |
| Support Level | $1.94 | $22.20 |
| Resistance Level | $2.08 | $24.33 |
| Average True Range (ATR) | 0.09 | 1.08 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 46.94 | 62.69 |
Price Performance
Historical ComparisonAbout GEVO Gevo Inc.
Gevo Inc is a renewable chemicals and biofuels company engaged in the development and commercialization of alternatives to petroleum-based products based on isobutanol produced from renewable feedstocks. The operating segments are the Gevo segment, GevoFuels segment, and the GevoRNG segment. By its segments, it is involved in research and development activities related to the future production of SAF, commercial opportunities for other renewable hydrocarbon products and isobutanol, including the development of its biocatalysts, and the produces-pipeline quality methane gas captured from dairy cow manure. The company derives maximum revenue from the GevoRNG segment.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.